97 results match your criteria: "University hospital Saint Louis[Affiliation]"

Article Synopsis
  • The respiratory system is not just sterile; it contains a varied bacterial microbiome that plays a crucial role in children's immune response and respiratory infections.
  • This review investigates how bacteria in the mouth and upper respiratory tract affect the likelihood and severity of respiratory infections in kids from birth to adolescence.
  • Key findings indicate that a disrupted microbiome, known as dysbiosis, can lead to higher chances of recurrent infections, emphasizing the need for maintaining a healthy microbial balance for better respiratory health.
View Article and Find Full Text PDF

Purpose: Patients with IDH-mutant 1p/19q-codeleted grade 3 oligodendroglioma (O3) benefit from adding alkylating agent chemotherapy to radiotherapy (RT). However, the optimal chemotherapy regimen between procarbazine, 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU), and vincristine (PCV) and temozolomide (TMZ) remains unclear given the lack of randomized trial data comparing both regimens.

Methods: The objective was to assess the overall survival (OS) and progression-free survival (PFS) associated with first-line PCV/RT versus TMZ/RT in patients newly diagnosed with O3.

View Article and Find Full Text PDF

Background: Fatigue, cognitive impairment, anxiety, depression, and sleep disturbance are cancer-related behavioral symptoms that may persist years after early-stage breast cancer, affecting quality of life. We aimed to generate a predictive model of long-term cancer-related behavioral symptoms clusters among breast cancer survivors 4 years after diagnosis.

Methods: Patients with early-stage breast cancer were included from the CANcer TOxicity trial (ClinicalTrials.

View Article and Find Full Text PDF

Background: Managing postoperative pain effectively with an opioid-free regimen following laparoscopic surgery (LS) remains a significant challenge. Intraperitoneal instillation of ropivacaine has been explored for its potential to reduce acute postoperative pain, but its efficacy and safety are still under debate. This study aimed to evaluate the efficacy and safety of intraperitoneal instillation of ropivacaine for acute pain management following laparoscopic digestive surgery.

View Article and Find Full Text PDF

Background: The imbalance of skin microbiota in acne can induce changes leading to induction or to aggravation of chronic inflammatory lesions; complex mechanisms are involved. ( ribotypes RT4 and RT5 express more biofilm and are associated with inflammatory acne lesions. RT6 is a non-acne ribotype, beneficial for the skin.

View Article and Find Full Text PDF

Tyrosine kinase inhibitors efficacy in central nervous system (CNS) disease remains uncertain. Ponatinib was studied for CNS distribution in 16 patients with Philadelphia-positive acute lymphoblastic leukemia. Cerebrospinal fluid concentrations fell below the 40 nM threshold, suggesting suboptimal CNS exposure.

View Article and Find Full Text PDF

EuroGuiderm guideline on lichen sclerosus-Treatment of lichen sclerosus.

J Eur Acad Dermatol Venereol

October 2024

Division of Evidence-Based Medicine (dEBM), Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Article Synopsis
  • Lichen sclerosus (LS) is a skin condition primarily affecting the anogenital area, causing symptoms like itching, soreness, and potential sexual and urinary dysfunction, with a risk of genital cancer and significant impacts on quality of life.
  • The guideline aims to improve the diagnosis and treatment of LS, offering evidence-based recommendations for different therapies and care approaches, especially during pregnancy and follow-up.
  • Topical corticosteroids are the primary treatment for LS in both sexes, with surgery as an option for males if standard treatments fail, while UV light therapy is suggested for non-genital LS, despite limited research.
View Article and Find Full Text PDF

EuroGuiderm guideline on lichen sclerosus-introduction into lichen sclerosus.

J Eur Acad Dermatol Venereol

October 2024

Department of Dermatology, Venereology and Allergology, Division of Evidence- Based Medicine (dEBM), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Article Synopsis
  • Lichen sclerosus (LS) is an inflammatory skin condition primarily affecting the anogenital area, leading to symptoms like itching, soreness, and potentially serious complications such as urinary and sexual dysfunction, along with an increased risk of genital cancer.
  • *The guideline aims to provide a comprehensive approach for diagnosing and treating LS, including recommendations for topical and surgical treatments, as well as care considerations for patients during pregnancy and ongoing management.
  • *Topical corticosteroids are considered the standard treatment for LS, with additional options like emollients and, if ineffective, surgical interventions such as circumcision for males; UV light therapy is also suggested for non-genital forms of LS despite limited evidence.
View Article and Find Full Text PDF

Heart failure is the most common cardiovascular complication during pregnancy and the postpartum period. It is associated with increased risk of maternal morbidity and mortality as well as potentially life-threatening foetal pathology. Management of heart failure in pregnancy requires expert knowledge of cardiovascular disease as well as obstetrics which underscores the importance of multidisciplinary cardio-obstetrics teams in order to optimize diagnosis, treatment and outcome.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates genomic imbalances in 317 newly diagnosed T-cell acute lymphoblastic leukemia (T-ALL) patients using single nucleotide polymorphism (SNP) array analysis, focusing on clinical features and outcomes.* -
  • The majority of patients (approximately 96%) showed at least one genomic imbalance, with del(9)(p21) being the most common, followed by other significant deletions involving various chromosomal regions.* -
  • The research identified specific genomic patterns related to age and subclassifications of T-ALL, and established a threshold of 15 imbalances for defining high- and low-risk relapse groups, highlighting the importance of genomic complexity in predicting survival outcomes.*
View Article and Find Full Text PDF

Experts from the European Leukemia Net (ELN) working group for adult acute lymphoblastic leukemia have identified an unmet need for guidance regarding management of adult acute lymphoblastic leukemia (ALL) from diagnosis to aftercare. The group has previously summarized their recommendations regarding diagnostic approaches, prognostic factors, and assessment of ALL. The current recommendation summarizes clinical management.

View Article and Find Full Text PDF

Working groups of the European LeukemiaNet have published several important consensus guidelines. Acute lymphoblastic leukemia (ALL) has many different clinical and biological subgroups and the knowledge on disease biology and therapeutic options is increasing exponentially. The European Working Group for Adult ALL has therefore summarized the current state of the art and provided comprehensive consensus recommendations for diagnostic approaches, biologic and clinical characterization, prognostic factors, and risk stratification as well as definitions of endpoints and outcomes.

View Article and Find Full Text PDF

Background: Textbook oncologic outcome (TOO) is a composite metric shown to correlate with improved survival after curative intent oncologic procedures. Despite increasing use among disciplines in surgical oncology, no consensus exists for its definition in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

Study Design: An international consensus-based study employed a Delphi methodology to achieve agreement.

View Article and Find Full Text PDF

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are examples of severe cutaneous adverse reactions to drugs (SCARs) with several international recommendations for global medical management, ranging from pharmacological systemic therapy to skin wound care. There is no defined best management of the skin wounds in SJS/TEN. The care of wounds is essential to initiate re-epithelialization.

View Article and Find Full Text PDF

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a drug reaction commonly related to eosinophilia, from uncertain epidemiology, and without consensus for diagnosis and treatment globally. It presents a great challenge in its management and is characterized by fever, lymphadenopathy, skin rash, and multisystemic involvement. An aggressive and difficult-to-manage clinical case is presented in a 50-year-old man with chronic kidney disease due to diabetes mellitus type 2 and systemic arterial hypertension, who developed an unusual variant similar to DRESS and Stevens-Johnson syndrome (SJS) overlap secondary to allopurinol, with skin manifestations without eosinophilia, but fulfilling clinical and laboratory criteria for DRESS and SJS syndrome.

View Article and Find Full Text PDF

Background: Children and young adults have a vast array of electronics at their fingertips. While it can provide endless hours of entertainment and education, we are also seeing a structural consequence. Children are using these devices with their head tilted down with poor posture resulting in increased stress on the skull from attached structures which can lead to a bone spur (exostosis) at the external occipital protuberance (EOP).

View Article and Find Full Text PDF

European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia.

Leukemia

November 2023

Department of Medical and Surgical Sciences, Institute of Hematology "Lorenzo e Ariosto Seràgnoli", University of Bologna, Bologna, Italy.

From the laboratory perspective, effective management of patients with chronic myeloid leukemia (CML) requires accurate diagnosis, assessment of prognostic markers, sequential assessment of levels of residual disease and investigation of possible reasons for resistance, relapse or progression. Our scientific and clinical knowledge underpinning these requirements continues to evolve, as do laboratory methods and technologies. The European LeukemiaNet convened an expert panel to critically consider the current status of genetic laboratory approaches to help diagnose and manage CML patients.

View Article and Find Full Text PDF

The reintegration of excised signal joints resulting from human V(D)J recombination was described as a potent source of genomic instability in human lymphoid cancers. However, such molecular events have not been recurrently reported in clinical patient lymphoma/leukemia samples. Using a specifically designed NGS-capture pipeline, we here demonstrated the reintegration of T-cell receptor excision circles (TRECs) in 20/1533 (1.

View Article and Find Full Text PDF

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy with a dismal prognosis related to refractory/relapsing diseases, raising the need for new targeted therapies. Activating mutations of interleukin-7-receptor pathway genes (IL-7Rp) play a proven leukemia-supportive role in T-ALL. JAK inhibitors, such as ruxolitinib, have recently demonstrated preclinical efficacy.

View Article and Find Full Text PDF

Background: For ventilator-associated pneumonia (VAP), the safety of short-course versus long-course antibiotic therapy is still debated, especially regarding documented VAP due to non-fermenting Gram-negative bacilli (NF-GNB). The aim of this meta-analysis was to assess the rates of recurrence and relapse of VAP in patients receiving short-course (≤8 days) and long-course (≥10-15 days) of antibiotic therapy.

Methods: The protocol for this study was registered in the PROSPERO database (ID: CRD42022365138).

View Article and Find Full Text PDF

Harnessing the MYB-dependent TAL1 5'super-enhancer for targeted therapy in T-ALL.

Mol Cancer

January 2023

Université de Paris Cité, Institut Necker Enfants-Malades INEM, Institut National de La Santé Et de La Recherche Médicale (Inserm), U1151, Paris, France.

Article Synopsis
  • Scientists found that certain changes in genes can cause cancer, specifically in a type called T-cell acute lymphoblastic leukemia (T-ALL).
  • They discovered that a specific mutation in a gene (TAL1) signals which patients might have a worse outcome, regardless of other gene activity.
  • Mebendazole, a medicine, can help treat T-ALL by breaking down a protein linked to the mutation, showing that new treatments could be developed targeting these genetic issues.
View Article and Find Full Text PDF

Psoriasis is not optimally controlled in spite of newly developed treatments, possibly due to the difficulty of objectively quantifying the disease's severity, considering the limitations of the clinical scores used in clinical practice. A major challenge addresses difficult-to-treat areas, especially in the absence of significant body surface involvement. It is controversial whether the severity evaluation of patients with several affected areas (having at least one difficult-to-treat area) should be done differently from current methods.

View Article and Find Full Text PDF

Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: a study of the SFGM-TC.

Bone Marrow Transplant

January 2023

Sorbonne University, INSERM UMR-S 938, Saint-Antoine Research Centre, AP-PH, Department of Clinical Hematology and Cellular Therapy, Saint-Antoine Hospital, Paris, France.

Relapsed B-cell acute lymphoblastic leukemia (B-ALL) after allogeneic stem cell transplantation (allo-HCT) still represents a major concern with poor outcomes. The aim of this study is to compare the efficacy and safety of blinatumomab and donor lymphocyte infusion (DLI) versus blinatumomab alone in this setting. This is a multicenter retrospective study from centers of SFGM-TC.

View Article and Find Full Text PDF